Prostate cancer treatment: Seed implants
Prostate Brachytherapy (Radioactive Seed Implantation) is a procedure to implant radioactive “seeds” into the prostate gland to kill prostate cancer cells.
Seed implantation is often used for men with smaller prostate cancer that is found early and is slow-growing. This form of treatment is well-tolerated, with very few side effects. Patients are able to return to work and normal activities within just a few days after the procedure to place the seeds.
The medical team at Cone Health Cancer Center uses cutting-edge software and intraoperative planning to examine three dimensional images of the prostate, and optimize seed distribution using ultrasound guidance. The radiation oncologists use robotic seed placement techniques, which have made the results much more uniform and consistent.
This advanced technology also assists the radiation oncologists in ensuring optimal seed quality, and monitoring the patient long-term. Cone Health Cancer Center’s radiation oncologists and medical staff collaborate with urologists and other related healthcare providers throughout the community to develop treatment plans individualized to each patient’s needs.
As a part of this multidisciplinary clinical approach and commitment to exceptional care, Cone Health Cancer Center has now administered 2,200 prostate implant procedures since 1993, and continues to serve as a leader in this type of cancer treatment as it has fewer complications and side effects than standard radiation therapy.
Dr. Robert Murray is the medical direction of the radiation oncology department at Cone Health Cancer Center and a leading expert on prostate implant procedures. Dr. Murray is a 1980 graduate of University of Virginia Medical Center and completed his residency in radiation oncology at the University of Virginia.